The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.00
Ask: 66.00
Change: 1.00 (1.56%)
Spread: 2.00 (3.125%)
Open: 64.00
High: 65.50
Low: 64.00
Prev. Close: 64.00
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update & Directorate Change

14 May 2013 07:00

RNS Number : 6148E
MyCelx Technologies Corporation
14 May 2013
 



MyCelx Technologies Corporation

("MyCelx" or the "Company") (AIM: MYX)

14 May 2013

 

Operational Update & Directorate Change

 

MyCelx Technologies, Inc (AIM: MYX), the clean water technology and engineering company providing patented solutions to the Oil and Gas industry and other commercial industrial markets worldwide, today announces an operational update and directorate change.

 

Operations

 

MyCelx is pleased to confirm that it continues to trade in line with market expectations.

 

The Company's expansion in recent years means that it has now outgrown its current head office in Gainesville, Georgia, and has recently acquired new offices in Duluth, Georgia, to house its corporate headquarters, laboratory and production facilities, and research and development department. The new head office will be operational from the beginning of June 2013.

 

In addition, the Company's Houston engineering and technology demonstration centre is now fully operational, and includes a demonstration system consisting of a MyCelx Advanced Coalescer, REGEN and Polisher. During the week of the global industry oil and gas Offshore Technology Conference which took place in Houston from 6 May to 10 May, the Company hosted a number of major international oil companies at its Houston office to view the MyCelx demonstration system in live operation. A video of the system in operation will shortly be available on the Company's website.

 

The Company has also further strengthened its capabilities with the addition of new engineering and sales personnel in the Middle East, Houston and London.

 

Directorate Change

 

The Board of MyCelx announces that it has been informed by John Mansfield Sr., Non-Executive Vice Chairman, of his wish to retire as a Director with immediate effect for health reasons. 

 

The Board has resolved to bestow upon Mr Mansfield the title of Chairman Emeritus upon his retirement.

 

Tim Eggar, Chairman, said: "The Board wishes to express its deepest appreciation to Mr Mansfield, the Company's former Chairman and co-founder, for his service to the Company. Mr Mansfield was instrumental in the Company's early development, providing funding and expertise to support its growth into a revolutionary oil-free water technology company with customers across the world."

 

Brian Rochester, Non-executive Director, has been appointed as Chairman of the Compensation Committee, and Swinton Griffith, Non-executive Director, has been appointed as a member of the Governance and Nomination Committee, with effect 15 May 2013.

 

 

- ends -

 

For further information please contact:

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

Tel: +1 888 306 6843

 

Numis Securities Limited

Corporate Finance

Stuart Skinner

Jamie Loughborough

 

Corporate Broking

James Black

Ben Stoop

Tel: +44 20 7260 1000

 

Pelham Bell Pottinger

Mark Antelme

Nick Lambert

Tel: +44 20 7861 3232

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMKLFLGFZM
Date   Source Headline
16th Mar 20167:00 amRNSAppointment of CFO/Grant of Share Options
4th Mar 20161:25 pmRNSHolding(s) in Company
4th Mar 20167:00 amRNSTrading Update
11th Jan 20165:30 pmRNSHolding(s) in Company
29th Dec 20152:23 pmRNSHolding(s) in Company
18th Dec 201510:13 amRNSHolding(s) in Company
15th Dec 20155:25 pmRNSHolding(s) in Company
15th Dec 20155:24 pmRNSHolding(s) in Company
11th Dec 20157:00 amRNSTrading Update
3rd Dec 201511:33 amRNSBlocklisting Interim Review
1st Oct 20157:00 amRNSProgress Update on Trials
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.